The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas

Clinical Endocrinology

Volumn 62, Issue 4, 2005, Pages 504-508

  Takeda, Yoshiyu ^a   Usukura, Mikiya ^a   Yoneda, Takashi ^a   Oda, Nobushige ^a   Ito, Yoko ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; INOSITOL TRISPHOSPHATE; LOSARTAN; MESSENGER RNA;

ADENOMA; ADRENAL CORTEX; ADRENAL GLAND; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ADP-RIBOSYL CYCLASE; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSINS; CASE-CONTROL STUDIES; CYCLIC ADP-RIBOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; IMIDAZOLES; LOSARTAN; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 17044385332     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02258.x     Document Type: Article

References (24)

1. Foster, R.H., MacFarlane, C.H. & Bustamante, M.O. (1997) Recent progress in understanding aldosterone secretion. General Pharmacology, 28, 647-651.
2. Woodcock, E.A. & McLeod, J.K. (1996) Adenylate cyclase inhibition is not involved in the adrenal steroidogenic response to angiotensin II. Endocrinology, 119, 1697-1702.
3. Lee, H.C. (1997) Mechanisms of calcium signaling by cyclic ADP-ribose and NAADP. Physiological Reviews, 77, 1133-1164.
4. Lee, H.C. (1994) A signaling pathway involving cyclic ADP-ribose, cGMP, and nitric oxide. News in Physiological Sciences, 9, 134-137.
5. Li, P.-L., Tang, W.-X., Valdivia, H.H., Zou, A.-P. & Campbell, W.B. (2001) cADP-ribose activates reconstituted ryanodine receptors from coronary arterial smooth muscle. American Journal of Physiology, Heart and Circulatory Physiology, 280, H208-H215.
6. Takasawa, S., Nata, K., Yonekura, H. & Okamoto, H. (1993) Cyclic ADP-ribose in insulin secretion from pancreatic cells. Science, 259, 370-373.
7. Toledo, F.G.S., Cheng, J., Liang, M., Chili, E.N. & Dousa, T.P. (2000) ADP-ribosyl cyclase in rat vascular smooth muscle cells. Circulation Research, 96, 1153-1159.
8. Higashida, H., Zhang, J.-S., Hashii, M., Shintaku, M., Higashida, C. & Takeda, Y. (2000) Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes. Biochemical Journal, 352, 197-202.
9. Takeda, Y., Furukawa, K., Inaba, S., Miyamori, I. & Mabuchi, H. (1999) Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism, 84, 1633-1637.
10. Takeda, Y., Miyamori, I., Inaba, S., Furukawa, K., Hatakeyama, H., Yoneda, T., Mabuchi, H. & Takeda, R. (1997) Vascular aldosterone in genetically hypertensive rats. Hypertension, 29, 45-48.
11. Chini, E.N., Toledo, F.G.S., Thompson, M.A. & Dousa, T.P. (1997) Effect of estrogen upon cyclic ADP ribose metabolism: β-estradiol stimulates ADP ribosyl xylase in rat uterus. Proceedings of the National Academy of Sciences of the United States of America, 94, 5872-5876.
12. Takeda, Y., Miyamori, I., Yoneda, T., Hatakeyama, H., Inaba, S., Furukawa, K. & Mabuchi, H. (1996) Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. Journal of Clinical Endocrinology and Metabolism, 81, 2797-2800.
13. Naka, K., Takamura, T., Karasawa, T., Kumaggi, T., Hashioka, W., Tohgo, A., Tonekura, H., Takasawa, S., Nakamura, S. & Okamoto, H. (1997) Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing. Gene, 186, 285-292.
14. Takeda, Y., Yoneda, T., Demura, M., Miyamori, I. & Mabuchi, H. (2000) Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology, 141, 1901-1904.
15. Wu, K.-D., Chen, Y.-M., Chu, J.-S., Hung, K.-Y., Hsieh, T.-S. & Hsieh, B.-S. (1995) Zona fasculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism, 80, 783-789.
16. Takeda, Y., Lewicka, S., Koch, S., Bige, K., Vecsei, P., Abdelhamid, S., Cojocaru, M. & Harnik, M. (1990) Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. Journal of Steroid Biochemistry and Molecular Biology, 37, 599-604.
17. Timmermans, P.B.M.W.M., Benfield, P., Chiu, A.T., Herblin, W.F., Wong, P.C. & Smith, R.D. (1992) Angiotensin II receptors and functional correlates. American Journal of Hypertension, 5, 221S-235S.
18. Stowasser, M. (2000) Primary aldosteronism: review of a syndrome. Journal of Hypertension, 18, 363-366.
19. Clyne, C.D., Zhang, Y, Slutsker, L., Mathis, J.M., White, P.C. & Rainey, W.E. (1997) Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Molecular Endocrinology, 11, 638-649.
20. Nawata, H., Takayanagi, R., Ohnaka, K., Sakai, Y., Imasaki, K., Yanase, T., Ikuyama, S., Tanaka, S. & Ohe, K. (1995) Type 1 angiotensin II receptors of adrenal tumors. Steroids, 60, 28-34.
21. Chen, Y.-M., Wu, K.-D., Hu-Tsai, M.-I., Chu, J.-S., Lai, M.-K. & Hsieh, B.-S. (1999) Differential expression of type 1 angiotensin II receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. Molecular and Cellular Endocrinology, 152, 47-55.
22. Takeda, Y. (2001) Genetic alterations in patients with primary aldosteronism. Hypertension Research, 24, 469-474.
23. Fardella, C.E., Rodriguez, H., Hum, D.W., Mellon, S.H. & Miller, W.L. (1995) Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? Journal of Clinical Endocrinology and Metabolism, 80, 1040-1043.
24. Parma, J., Duprez, L., Sande, V., Cochaux, P., Gervy, C. & Mockel, J. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature, 365, 649-651.